The U.S. Supreme Court’s recent unanimous decision in Cunningham v. Cornell University has altered the litigation landscape for benefit plan fiduciaries and their insurers. Understanding those changes ...

Employers are questioning what Food and Drug Administration approval of glucagon-like peptide-1, or GLP-1, medications could mean for their health plans, according to recent survey data. The past two ...

It's easy to think that workers care the most about pay—after all, that's typically why they work. But equally important to most workers are the company's health benefits. In fact, 73% of small ...